Onsdag 28 Oktober | 17:16:23 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Lipum Q1 report - Ahead of time

2023-04-25 11:25:00

Redeye provides a research update on Lipum following the Q1 report published by the company earlier today. We make some slight adjustments to our OPEX estimates following slightly lower reported R&D costs than expected. However, we reiterate our previous fair value range (SEK5 – SEK35) with a base case valuation of SEK22 as we continue to see significant upside potential in the stock.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/